Will Chang is the founder of NGM Biopharmaceuticals. NGM Biopharmaceuticals has raised $26M in total funding. Latest round: Series A.
William Chang serves as the Vice President of Clinical Operations at NGM Biopharmaceuticals. He has extensive experience in the biotech and pharmaceutical sectors, managing global Phase 1-4 clinical trials across four continents and over 30 countries. William provides strategic oversight for all clinical operations activities and focuses on innovative clinical trial programs across multiple therapeutic areas.
Full founder directory · Investor directory · Company funding database · Fundraising library